approval of the pill form in December
This includes identifying potential adverse events, understanding their frequency and severity, and evaluating any risks related to immunogenicity, vascular proliferation, or hormonal interactions
Connexin hemichannels in atrial fibrillation: orphaned and irrelevant
of this final rule with comment period, where we discuss our proposal to amend the hospital price transparency regulations at 45 CFR 180 to require that, beginning January 1, 2026, hospitals would report a new data element, the median allowed amount, instead of the estimated allowed amount reported at present, and that the median allowed amount would be defined as the median of the total allowed amounts that the hospital has historically received from a third-party payer (including MAOs) for an item or service
Summary: Victoza (liraglutide) does not directly cause urine odour changes according to official UK regulatory documentation and clinical trials
If an independent re-test ever shows a batch falls short of its stated purity, we replace it free
